The largest database of trusted experimental protocols

Wako autokit 3 hb

Manufactured by Fujifilm
Sourced in Japan

The Wako Autokit 3-HB is a laboratory equipment product designed for the quantitative determination of 3-hydroxybutyrate (3-HB) in biological samples. It provides an automated and standardized method for the analysis of 3-HB levels.

Automatically generated - may contain errors

6 protocols using wako autokit 3 hb

1

Plasma Beta-Hydroxybutyrate Determination

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood was taken from the facial vein or submandibular vein using Goldenrod Animal Lancet (MEDIpoint, Inc, NY, USA) 30 minutes after oral injection of vehicle or C10 (0.3, 3.0, or 30 mmol/kg) in mice, which were experimentally naive before the oral gavage (Veh, n = 5; 0.3 mmol/kg, n = 6; 3.0 mmol/kg, n = 6; 30 mmol/kg, n = 6). Additionally, trunk blood was collected from three groups of mice used in Experiment 3 (Veh, n = 16; 0.3 mmol/kg, n = 16; 3.0 mmol/kg, n = 13) approximately 24 hours after the tail suspension test followed by the last oral administration (1 day after the 28 days treatment of C10). Blood samples were placed in tubes containing sodium heparin (FUJIFILM Wako Pure Chemical Corp., Osaka, Japan) and centrifuged at 3000 g for 10 minutes at 4°C. Supernatants were collected and stored at −80°C until measurement. Plasma BHB levels were determined using the Wako Autokit 3‐HB (FUJIFILM Wako Pure Chemical Corp., Osaka, Japan) according to the manufacturer's instructions.
+ Open protocol
+ Expand
2

Plasma Metabolite Analysis Methods

Check if the same lab product or an alternative is used in the 5 most similar protocols
A Technicon Autoanalyzer (Technicon Instruments Corp.) was used to measure plasma concentrations of glucose (Bran and Luebbe Industrial Method 339-19; Gochman and Schmitz, 1972) (link) and BUN (Bran and Luebbe Industrial Method 339-01; Marsh et al., 1965) (link). Intra-and interassay CV were 3.8 and 3.3% for glucose and 3.7 and 4.6% for BUN, respectively. Concentrations of fatty acids (NEFA-C kit, Wako Diagnostics Inc.; as modified by Johnson and Peters, 1993) (link) and BHB (Wako Autokit 3-HB; Wako Diagnostics Inc.) were determined in duplicate. Inter-and intra-assay CV were 3.2 and 8.8% and 2.7 and 9.8% for fatty acids and BHB, respectively. For plasma concentrations of TAG (Stanbio Triglycerides LiquiColor Procedure No. 2100, Stanbio Laboratory), intra-and interassay CV were 4.0 and 8.4%, respectively. Plasma total Ca and Zn were determined using an atomic absorption spectrophotometer. Inter-and intra-assay CV were 1.4 and 6.7% for total Ca and 2.4 and 8.7% for Zn, respectively.
+ Open protocol
+ Expand
3

Plasma Metabolite Profiling in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice were typically fasted for 6 hours starting at 8:30 am unless otherwise indicated. Blood samples were collected from the saphenous vein using heparinized capillary tubes and centrifuged at 4600 RCF for 9 minutes at 4 °C to obtain plasma. Plasma free fatty acids were measured using the Wako HR Series NEFA-HR(2) kit (Wako Diagnostics, #999-3469, #995-34791, #991-34891, #993-35191). Plasma glycerol and triglycerides were measured with the Serum Triglyceride Determination Kit (Sigma-Aldrich, #TR0100). Plasma β-hydroxybutyrate was measured using the Wako Autokit 3-HB (Wako Diagnostics, #417-73501, #413-73601). Plasma cholesterol was measured using the Wako Cholesterol E reagent (Wako Diagnostics, #999-02601). Lipoprotein profiles were generated by the Vanderbilt University Mouse Metabolic Phenotyping Center. Blood glucose was measured using a Nova Max Plus glucometer (Nova Diabetes Care) and plasma insulin levels were measured using the Stellux Chemi Rodent Insulin ELISA (Alpco, 80-INSMR-CH01).
+ Open protocol
+ Expand
4

Plasma Biomarkers of Peripartum Metabolic Status

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples were collected by venipuncture of the tail vessels using evacuated tubes containing EDTA as the anticoagulant at 4, 7, 10, and 14 DIM. Blood samples were placed on ice until processing. Within 6 h of collection, samples were centrifuged and plasma was harvested and frozen at -80°C until analysis. Commercial kits were used to determine plasma concentrations of NEFA (NEFA-C kit; Wako Diagnostics Inc., Richmond, VA; as modified by Johnson and Peters, 1993) and BHB (Wako Autokit 3-HB; Wako Diagnostics Inc.) as previously reported (Martinez et al., 2012) . Inter-and intraassay coefficients of variation were 6.3 and 4.5% for NEFA, and 8.5 and 3.6% for BHB, respectively. Plasma concentration of haptoglobin was determined using a colorimetric method based on peroxidase activity as previously described (Cooke and Arthington, 2013) . Inter-and intraassay coefficients of variation were 3.2 and 9.0%.
+ Open protocol
+ Expand
5

Analytical Methods for Metabolic Biomarkers

Check if the same lab product or an alternative is used in the 5 most similar protocols
All assays followed the initial randomization with blocks, such that samples from each block were analyzed in the same assay. Plasma concentrations of NEFA (NEFA-C kit; Wako Diagnostics Inc., Richmond, VA; according to Johnson and Peters, 1993) and BHB (Wako Autokit 3-HB; Wako Diagnostics, Inc.) were analyzed using colorimetric enzymatic assays. The intra-and interassay coefficients of variation (CV) were, respectively, 3.4 and 8.4% for NEFA and 1.0 and 4.0% for BHB. Concentrations of glucose in plasma were determined by colorimetric continuous flow analysis (Autoanalyzer II, Seal Analytical, Southampton, UK) using a modification of the method described by Gochman and Schmitz (1972) . Plasma concentrations of tCa and tMg were analyzed by atomic absorption using a spectrophotometer equipped with Ca-and Mg-specific hollow cathode lamps (AAnalyst 200, Perkin-Elmer Inc., Waltham, MA) as described by Martinez et al. (2012) . Intra-and interassay CV were, respectively, 1.8 and 5.1% for tCa and 1.6 and 4.4% for tMg. Concentrations of tP were quantified in plasma using the molybdenum blue method (Quinlan and DeSesa, 1955) . The intra-and interassay CV were, respectively, 3.4 and 10.1%.
+ Open protocol
+ Expand
6

Plasma Metabolite Analysis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma concentrations of NEFA (NEFA-C kit; Wako Diagnostics Inc., Richmond, VA; according to Johnson and Peters, 1993) and BHB (Wako Autokit 3-HB; Wako Diagnostics Inc.) were analyzed using colorimetric enzymatic assays. The intra-and interassay coefficients of variation (CV) were, respectively, 9.2 and 4.8% for NEFA, and 9.8 and 5.9% for BHB. Concentrations of glucose in plasma were determined by colorimetric continuous flow analysis (Autoanalyzer II, Seal Analytical, Southampton, UK) using a modification of the method described by Gochman and Schmitz (1972) ). The intra-and interassay CV were 4.5 and 4.7%, respectively. Details of assays of vitamin D metabolites in plasma and iCa in whole blood are presented in a companion paper (Rodney et al., 2018) .
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!